Related Experiment Videos
Antibiotic usage in pelvic infections. An overview
1Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030.
The Journal of Reproductive Medicine
|June 1, 1988
Summary
Postoperative pelvic infections in women are often caused by multiple bacteria. A new treatment combines a broad-spectrum antibiotic with a beta-lactamase inhibitor to combat resistant bacteria.
Area of Science:
- Gynecology
- Infectious Diseases
- Pharmacology
Background:
- Postoperative soft-tissue pelvic infections in women are typically polymicrobial, involving both aerobic and anaerobic bacteria.
- Antibiotic prophylaxis is used to prevent infections like postcesarean endometritis and post-vaginal hysterectomy pelvic infection.
- Antibiotic use can lead to the selection of resistant bacteria, many of which produce beta-lactamase enzymes.
Purpose of the Study:
- To introduce a novel therapeutic approach for managing postoperative pelvic infections.
- To address the challenge of beta-lactamase-producing bacteria in pelvic infections.
Main Methods:
- Investigating the efficacy of combining beta-lactamase inhibitors with broad-spectrum antibiotics.
- Evaluating ticarcillin disodium plus clavulanate potassium (Timentin) as a treatment option.
Main Results:
- The combination therapy targets polymicrobial infections effectively.
- Beta-lactamase inhibitors neutralize resistance mechanisms in bacteria.
Conclusions:
- Combining beta-lactamase inhibitors with broad-spectrum antibiotics offers a promising strategy for treating postoperative pelvic infections.
- Ticarcillin disodium plus clavulanate potassium (Timentin) represents a new treatment approach for these infections.